sr 140333 has been researched along with Chronic Lung Injury in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreotti, N; Brégeon, F; Delpierre, S; Jammes, Y; Ravailhe, S; Sabatier, JM; Steinberg, JG | 1 |
| Bhatia, M; Hegde, A; Moochhala, SM; Zhang, H | 1 |
2 other study(ies) available for sr 140333 and Chronic Lung Injury
| Article | Year |
|---|---|
Substance P receptor blockade decreases stretch-induced lung cytokines and lung injury in rats.
Topics: Animals; Cytokines; Interleukin-1beta; Interleukin-6; Lung; Lung Injury; Models, Animal; Neurokinin-1 Receptor Antagonists; Piperidines; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Respiration, Artificial; Vagotomy; Vagus Nerve | 2010 |
Neurokinin-1 receptor antagonist treatment protects mice against lung injury in polymicrobial sepsis.
Topics: Animals; Cecum; Chemokines; Cytokines; Enzyme-Linked Immunosorbent Assay; Lung; Lung Diseases; Lung Injury; Male; Mice; Neurokinin-1 Receptor Antagonists; Neutrophils; Peroxidase; Piperidines; Protein Precursors; Quinuclidines; Receptors, Neurokinin-1; Sepsis; Stereoisomerism; Tachykinins | 2007 |